-
Gaia Announces Closing of Underwritten Offering of $8.0 Million of Common Stock
07 Feb 2025 21:01 GMT
… (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA) (“Gaia” or the “Company … shares of its Class A common stock at a price to the … , the shares of Class A common stock, nor will there be any … the shares of Class A common stock in any state or other …
-
PotlatchDeltic Board Declares Distribution on Common Stock
07 Feb 2025 19:51 GMT
… (Nasdaq: PCH) declared a quarterly distribution on the Company's common stock … 7, 2025.
About PotlatchDeltic
PotlatchDeltic (Nasdaq: PCH) is a leading Real …
-
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 Feb 2025 00:26 GMT
… (RSUs) of the company’s common stock to 34 newly hired non … with Evolus in accordance with Nasdaq Listing Rule 5635(c)(4 … , the closing price of Evolus’ common stock the date of grant. The … date.
About Evolus, Inc.
Evolus (NASDAQ: EOLS) is a global performance …
-
Red Cat Investor News: If You Have Suffered Losses in Red Cat Holdings, Inc. (NASDAQ: RCAT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
07 Feb 2025 22:43 GMT
… of Red Cat Holdings, Inc. (NASDAQ: RCAT) resulting from allegations that … , the price of Red Cat common stock fell $1.55 per share …
-
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07 Feb 2025 22:47 GMT
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage … shares of the Company’s common stock under the Gossamer Bio, Inc … with Gossamer in accordance with Nasdaq Listing Rule 5635(c)(4 … of Gossamer’s common stock as reported by The Nasdaq Global Select Market …
-
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Feb 2025 21:46 GMT
Incyte (Nasdaq:INCY) today announced that it … shares of the Company’s common stock to 24 new employees. The … the Company in accordance with Nasdaq Listing Rule 5635(c)(4 …
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07 Feb 2025 21:30 GMT
… NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology … closing price of ORIC’s common stock on the Grant Date. Twenty … of Directors, as required by Nasdaq Rule 5635(c)(4), … to employment in accordance with Nasdaq Rule 5635(c)(4). …
-
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07 Feb 2025 21:30 GMT
… NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology … 45,000 shares of its common stock under the Company’s 2023 …
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Feb 2025 21:30 GMT
… ) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical … shares of the company’s common stock pursuant to the company’ … shares of the company’s common stock at an exercise price … share of Fulcrum’s common stock as reported on the …
-
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07 Feb 2025 21:30 GMT
… (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical … common stock (RSUs) to two new non-executive employees. In accordance with NASDAQ …